G1 Therapeutics.

PositionTRIANGLE BRIEFS: RESEARCH TRIANGLE PARK

G1 Therapeutics raised $47 million in a funding led by Boston-based Cormorant Asset Management. Existing investors that participated in the financing include Wilmington-based Eshelman Ventures and Durham-based Hatteras Venture Partners. The biotech company plans...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT